These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23405973)

  • 1. Targeting nascent soluble Aβ42 for potential Alzheimer drug development.
    Zhang M; Hausmann L; Song W
    J Neurochem; 2013 May; 125(3):329-31. PubMed ID: 23405973
    [No Abstract]   [Full Text] [Related]  

  • 2. Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools.
    Mitani Y; Yarimizu J; Akashiba H; Shitaka Y; Ni K; Matsuoka N
    J Neurochem; 2013 May; 125(3):465-72. PubMed ID: 23240999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are γ-secretase inhibitors detrimental for Alzheimer's disease patients?
    Ross JS; Imbimbo BP
    J Alzheimers Dis; 2010; 22(2):401-4. PubMed ID: 21149978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient four-drug cocktail therapy targeting amyloid-β peptide for Alzheimer's disease.
    Asai M; Iwata N; Tomita T; Iwatsubo T; Ishiura S; Saido TC; Maruyama K
    J Neurosci Res; 2010 Dec; 88(16):3588-97. PubMed ID: 20890992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound CID 9998128 Is a Potential Multitarget Drug for Alzheimer's Disease.
    Thai NQ; Bednarikova Z; Gancar M; Linh HQ; Hu CK; Li MS; Gazova Z
    ACS Chem Neurosci; 2018 Nov; 9(11):2588-2598. PubMed ID: 29775277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's drug update. Harvard researchers help test new drugs that could strike at the root of Alzheimer's disease. Here's where things stand.
    Harv Mens Health Watch; 2013 Jan; 17(6):6-7. PubMed ID: 23819191
    [No Abstract]   [Full Text] [Related]  

  • 7. Quinazolinones as γ-secretase modulators.
    Fischer C; Shah S; Hughes BL; Nikov GN; Crispino JL; Middleton RE; Szewczak AA; Munoz B; Shearman MS
    Bioorg Med Chem Lett; 2011 Jan; 21(2):773-6. PubMed ID: 21190851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lead optimization of 4,4-biaryl piperidine amides as γ-secretase inhibitors.
    Close J; Heidebrecht R; Hendrix J; Li C; Munoz B; Surdi L; Kattar S; Tempest P; Moses P; Geng X; Hughes B; Smotrov N; Moxham C; Chapnick J; Kariv I; Nikov G; Burke JE; Deshmukh S; Jeliazkova-Mecheva V; Leach JK; Diaz D; Xu L; Yang Z; Kwei G; Moy L; Shah S; Tanga F; Kenefic C; Savage D; Shearman M; Ball RG; McNevin MJ; Markarewicz A; Miller T
    Bioorg Med Chem Lett; 2012 May; 22(9):3203-7. PubMed ID: 22483609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 - 2012).
    Belluti F; Rampa A; Gobbi S; Bisi A
    Expert Opin Ther Pat; 2013 May; 23(5):581-96. PubMed ID: 23425062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of arylquinones as BACE1 inhibitors, β-amyloid peptide aggregation inhibitors, and destabilizers of preformed β-amyloid fibrils.
    Ortega A; Rincón Á; Jiménez-Aliaga KL; Bermejo-Bescós P; Martín-Aragón S; Molina MT; Csákÿ AG
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2183-7. PubMed ID: 21441028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino-caprolactam γ-secretase inhibitors showing potential for the treatment of Alzheimer's disease.
    Neitzel ML; Aubele DL; Marugg JL; Jagodzinski JJ; Konradi AW; Pleiss MA; Szoke B; Zmolek W; Goldbach E; Quinn KP; Sauer JM; Brigham EF; Wallace W; Bova MP; Hemphill S; Basi G
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3715-20. PubMed ID: 21571529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease modifying drugs targeting β-amyloid.
    Ozudogru SN; Lippa CF
    Am J Alzheimers Dis Other Demen; 2012 Aug; 27(5):296-300. PubMed ID: 22815077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
    Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
    J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoimidazoles as BACE-1 inhibitors: the challenge to achieve in vivo brain efficacy.
    Swahn BM; Holenz J; Kihlström J; Kolmodin K; Lindström J; Plobeck N; Rotticci D; Sehgelmeble F; Sundström M; Berg Sv; Fälting J; Georgievska B; Gustavsson S; Neelissen J; Ek M; Olsson LL; Berg S
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1854-9. PubMed ID: 22325942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tarenflurbil: a shot on goal.
    Aisen PS
    Lancet Neurol; 2008 Jun; 7(6):468-9. PubMed ID: 18450518
    [No Abstract]   [Full Text] [Related]  

  • 17. An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease.
    Habchi J; Arosio P; Perni M; Costa AR; Yagi-Utsumi M; Joshi P; Chia S; Cohen SI; Müller MB; Linse S; Nollen EA; Dobson CM; Knowles TP; Vendruscolo M
    Sci Adv; 2016 Feb; 2(2):e1501244. PubMed ID: 26933687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iminoheterocycles as gamma-secretase modulators.
    Caldwell JP; Bennett CE; McCracken TM; Mazzola RD; Bara T; Buevich A; Burnett DA; Chu I; Cohen-Williams M; Josein H; Hyde L; Lee J; McKittrick B; Song L; Terracina G; Voigt J; Zhang L; Zhu Z
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5380-4. PubMed ID: 20724152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction to special issue on Alzheimer's disease.
    Wolfe MS
    J Med Chem; 2012 Nov; 55(21):8977-8. PubMed ID: 23039833
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of Abeta production by NF-kappaB inhibitors.
    Paris D; Patel N; Quadros A; Linan M; Bakshi P; Ait-Ghezala G; Mullan M
    Neurosci Lett; 2007 Mar; 415(1):11-6. PubMed ID: 17223266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.